ClinicalTrials.govpublic full text
Selinexor, Pomalidomide, and Dexamethasone With or Without Carfilzomib for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, The SCOPE Trial
recurrent multiple myeloma, refractory multiple myeloma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 834434
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.